AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 90 filers reported holding AKEBIA THERAPEUTICS INC in Q4 2015. The put-call ratio across all filers is 0.22 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,272 | +27.0% | 14,274 | +2.0% | 0.00% | – |
| Q2 2023 | $12,810 | -36.0% | 14,000 | +591.4% | 0.00% | – |
| Q2 2018 | $20,000 | -4.8% | 2,025 | -9.7% | 0.00% | – |
| Q1 2018 | $21,000 | -40.0% | 2,242 | -4.6% | 0.00% | – |
| Q4 2017 | $35,000 | -14.6% | 2,351 | +11.5% | 0.00% | – |
| Q3 2017 | $41,000 | +46.4% | 2,108 | +6.8% | 0.00% | – |
| Q2 2017 | $28,000 | +55.6% | 1,974 | -0.8% | 0.00% | – |
| Q1 2017 | $18,000 | +50.0% | 1,989 | +77.4% | 0.00% | – |
| Q4 2016 | $12,000 | -25.0% | 1,121 | -36.6% | 0.00% | – |
| Q3 2016 | $16,000 | +6.7% | 1,768 | -9.2% | 0.00% | – |
| Q2 2016 | $15,000 | -28.6% | 1,947 | -17.7% | 0.00% | – |
| Q1 2016 | $21,000 | -43.2% | 2,367 | -17.7% | 0.00% | – |
| Q4 2015 | $37,000 | – | 2,877 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 4,652,561 | $3,340,000 | 5.66% |
| Orchard Capital Management, LLC | 1,762,731 | $1,265,000 | 0.36% |
| Ikarian Capital, LLC | 1,200,000 | $860,000 | 0.11% |
| Ikarian Capital, LLC | 800,000 | $575,000 | 0.08% |
| XTX Topco Ltd | 102,392 | $74,000 | 0.03% |
| Nantahala Capital Management | 965,800 | $693,000 | 0.03% |
| Worth Venture Partners, LLC | 63,500 | $46,000 | 0.02% |
| Ardent Capital Management, Inc. | 43,429 | $31,000 | 0.02% |
| Virtus ETF Advisers LLC | 65,149 | $47,000 | 0.02% |
| RICE HALL JAMES & ASSOCIATES, LLC | 513,292 | $368,000 | 0.02% |